Eupraxia Pharmaceuticals Inc. (EPRX)
NASDAQ: EPRX · Real-Time Price · USD
3.800
0.00 (0.00%)
At close: May 9, 2025, 4:00 PM
3.800
0.00 (0.00%)
After-hours: May 9, 2025, 4:00 PM EDT
Eupraxia Pharmaceuticals Market Cap
Eupraxia Pharmaceuticals has a market cap or net worth of $138.87 million as of May 9, 2025. Its market cap has increased by 36.94% in one year.
Market Cap
138.87M
Enterprise Value
141.69M
1-Year Change
36.94%
Ranking
Category
Stock Price
3.80
Market Cap Chart
Since March 9, 2021, Eupraxia Pharmaceuticals's market cap has increased from $61.62M to $138.87M, an increase of 125.37%. That is a compound annual growth rate of 21.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 138.87M | 24.37% |
| Dec 31, 2024 | 111.66M | 0.72% |
| Dec 29, 2023 | 110.86M | 90.37% |
| Dec 30, 2022 | 58.23M | 111.19% |
| Dec 31, 2021 | 27.57M | -55.25% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |